Search Results - "Catamero, Donna"

Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data by Kaur, Gurbakhash, Mejia Saldarriaga, Mateo, Shah, Nishi, Catamero, Donna D., Yue, Lihua, Ashai, Nadia, Goradia, Niyati, Heisler, Joshua, Xiao, Zhengrui, Ghalib, Natasha, Aaron, Tonya, Cole, Daniel, Foreman, Rebecca, Mantzaris, Ioannis, Derman, Olga, Bachier, Lizamarie, Sica, R. Alejandro, Kornblum, Noah, Braunschweig, Ira, Shastri, Aditi, Goel, Sanjay, Verma, Amit, Janakiram, Murali

“…Multiple myeloma (MM) in Hispanics has never been studied. We therefore sought to determine the clinical characteristics and overall survival in MM of…”
Get full text

Immunotherapy in Multiple Myeloma by Gleason, Charise, Catamero, Donna D.

“…To review the use of monoclonal antibodies (mAbs) in the treatment of multiple myeloma (MM) and the management of most common side effects. Review of journal…”
Get full text

Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma by Coffey, David G, Osman, Keren, Aleman, Adolfo, Bekri, Selma, Kats, Simone, Dhadwal, Amishi, Catamero, Donna, Kim-Schulze, Seunghee, Gnjatic, Sacha, Chari, Ajai, Parekh, Samir, Jagannath, Sundar, Cho, Hearn Jay

“…BackgroundAutologous stem cell transplantation (ASCT) after induction therapy improves disease-free survival for patients with multiple myeloma (MM). While the…”
Get full text

Integrating Touchscreen-Based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma to Drive Personalized Treatment Decisions by Nathwani, Nitya, Kurtin, Sandra E, Lipe, Brea, Mohile, Supriya Gupta, Catamero, Donna D, Wujcik, Debra, Birchard, Kristy, Davis, Agnes, Dudley, William, Stricker, Carrie Tompkins, Wildes, Tanya Marya

“…Geriatric assessment (GA) results predict toxicity/survival in older adults, yet GA is not routinely used in care for patients with multiple myeloma (MM). We…”
Get more information

A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma by Chari, Ajai, Cho, Hearn J., Dhadwal, Amishi, Morgan, Gillian, La, Lisa, Zarychta, Katarzyna, Catamero, Donna, Florendo, Erika, Stevens, Nadege, Verina, Daniel, Chan, Elaine, Leshchenko, Violetta, Laganà, Alessandro, Perumal, Deepak, Mei, Anna Huo-Chang, Tung, Kaity, Fukui, Jami, Jagannath, Sundar, Parekh, Samir

“…Phase 3 studies combining histone deacetylase inhibitors with bortezomib were hampered by gastrointestinal (GI) intolerance, which was not observed when…”
Get full text

STANDARDIZING CARE OF MULTIPLE MYELOMA PATIENTS RECEIVING INVESTIGATIONAL CAR-T by You, Ashlee, Catamero, Donna

“…Clinical Trials offer patients novel therapies that may not have a commercially available equivalent. While investigational protocols dictate a schedule of…”
Get full text

Multiple Myeloma: Detecting Genetic Changes Through Bone Marrow Biopsy and the Influence on Care by Catamero, Donna

“…Knowledge of genetic mutations and how these affect patient outcomes is rapidly expanding in the care of individuals diagnosed with multiple myeloma (MM)…”
Get full text

Multiple Myeloma: Detecting genetic changes through bone marrow biopsy and the influence on care by Catamero, Donna

“…Knowledge of genetic mutations and how these affect patient outcomes is rapidly expanding in the care of individuals diagnosed with multiple myeloma (MM)…”
Get full text

Multiple Myeloma by Catamero, Donna

“…Knowledge of genetic mutations and how these affect patient outcomes is rapidly expanding in the care of individuals diagnosed with multiple myeloma (MM)…”
Get full text

NSP-02 Real World Experience of Talquetamab Administration and the Prevalence and Management of Associated Dermatological Toxicities by Catamero, Donna, Spencer, Patrick, Sanchez, Larysa, Rodriguez-Valdes, Cesar

Get full text

NSO-01 The Real World Experience of the Incidence, Assessment, and Management of Oral Adverse Events and Weight Loss With Talquetamab Leading to the Development of an Assessment Tool by Catamero, Donna, Spencer, Patrick, Sanchez, Larysa, Rodriguez-Valdes, Cesar

Get full text

MANAGING CYTOKINE RELEASE SYNDROME IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXPERIENCE WITH TECLISTAMAB IN THE MAJESTEC-1 STUDY by Catamero, Donna, Blazquez, Patricia, Shenoy, Samantha, Chastain, Katherine, Kruyswijk, Sandy

Get full text

NSO-01 Real world experience of teclistamab using a prompt management strategy for cytokine release syndrome by Catamero, Donna, Dai, Victoria, Rattu, Mohammad, Jagannath, Sundar, Rodriguez, Cesar

Get full text

NSP-12 Multiple myeloma and disparate populations: the path forward by Lu, Rebecca, Tariman, Joseph, Catamero, Donna, Hillengass, Michaela, Noonan, Kimberly

Get full text

Nursing Implications for Patients with Relapsed and/or Refractory Multiple Myeloma Receiving Combination Therapy with Daratumumab (Darzalex™) and Lenalidomide by Catamero, Donna, Spencer, Patrick

Get full text

NURSING CONSIDERATIONS FOR TALQUETAMAB DOSING IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA by Blazquez, Patricia, Chari, Ajai, Renaud, Thomas, Tolbert, Jaszianne, Gray, Kathleen, Catamero, Donna

“…Talquetamab is the first approved T-cell redirecting bispecific antibody targeting the novel antigen, G protein-coupled receptor class C group 5 member D…”
Get full text

MANAGING INFECTION RISK IN RELAPSED/ REFRACTORY MULTIPLE MYELOMA: NURSING EXPERIENCE WITH TECLISTAMAB IN THE MAJESTEC-1 STUDY by Kruyswijk, Sandy, van de donk, Niels, Doyle, Margaret, Chatain, Katherine, Trancucci, Danielle, Catamero, Donna

Get full text

TALQUETAMAB SKIN TOXICITIES: PRESENTATION AND MANAGEMENT GUIDELINES by Catamero, Donna, Purcell, Kiah, Urena, Annel, Ray, Chloe, Feuer, Julia, Leon, Yan

“…Symptom Management and Palliative Care Talquetamab is a T-cell redirecting bispecific antibody that targets a novel antigen, GPRG5D, on myeloma cells and GD3…”
Get full text

MANAGEMENT CONSIDERATIONS FOR ORAL TOXICITIES ASSOCIATED WITH TALQUETAMAB, A GPRC5D×CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA by Shenoy, Samantha, Leahey, Sheryl, Catamero, Donna, O'Rourke, Lisa, Gray, Kathleen, Rogers, Stephanie

Get full text

Nursing implications for multiple myeloma patients undergoing chimeric antigen receptor (CAR) T-cell therapy by Florendo, Erika, Catamero, Donna, Mancia, Ines Stefania

Get full text